What Matters Most to Patients with NSCLC When Choosing Anticancer Treatments in China? A Best-Worst Scaling Study.

Patient Prefer Adherence · 2026 · PMC13003994 · PMID 41868731

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

did not reach statistical significanceP ≥ 0.05actually significant

Adverse events such as nausea/vomiting ( β= –0.005), fever ( β= 0.048), and cough ( β= –0.185) did not reach statistical significance ( P ≥ 0.05), indicating limited influence on overall preferences.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.